MX357329B - Extracto crudo de un hibrido de sechium edule, metodo para su extraccion y su uso para formulaciones con efecto antineoplasico. - Google Patents

Extracto crudo de un hibrido de sechium edule, metodo para su extraccion y su uso para formulaciones con efecto antineoplasico.

Info

Publication number
MX357329B
MX357329B MX2012003818A MX2012003818A MX357329B MX 357329 B MX357329 B MX 357329B MX 2012003818 A MX2012003818 A MX 2012003818A MX 2012003818 A MX2012003818 A MX 2012003818A MX 357329 B MX357329 B MX 357329B
Authority
MX
Mexico
Prior art keywords
hybrid
sechium edule
formulations
raw extract
var
Prior art date
Application number
MX2012003818A
Other languages
English (en)
Other versions
MX2012003818A (es
Inventor
Santiago Osorio Edelmiro
Aguiñiga Sánchez Itzen
Cadena Iñiguez Jorge
Marcos Soto Hernández Ramón
Manuel Cisneros Solano Victor
De Lourdes Catalina Arévalo Galarza Ma
Rocío Rivera Martínez Ana
Original Assignee
Itzen Aguiniga Sanchez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Itzen Aguiniga Sanchez filed Critical Itzen Aguiniga Sanchez
Priority to MX2012003818A priority Critical patent/MX357329B/es
Priority to PCT/MX2013/000031 priority patent/WO2013147578A1/es
Priority to EP13769895.7A priority patent/EP2886124A4/en
Priority to US14/388,405 priority patent/US20150064289A1/en
Publication of MX2012003818A publication Critical patent/MX2012003818A/es
Publication of MX357329B publication Critical patent/MX357329B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica que contiene un extracto crudo del híbrido H387-07-GISeM, producto de los cruzamientos entre las variedades: Sechium edule var. virens levis por Sechium edule var. amarus silvestrys y su resultante por Sechiurn edule var. nigrum spinosum, el cual presenta actividad terapéutica como agente antineoplásico, dicha composición tiene un efecto mejorado respecto a sus progenitores y además no presenta efectos colaterales durante su administración.
MX2012003818A 2012-03-28 2012-03-28 Extracto crudo de un hibrido de sechium edule, metodo para su extraccion y su uso para formulaciones con efecto antineoplasico. MX357329B (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
MX2012003818A MX357329B (es) 2012-03-28 2012-03-28 Extracto crudo de un hibrido de sechium edule, metodo para su extraccion y su uso para formulaciones con efecto antineoplasico.
PCT/MX2013/000031 WO2013147578A1 (es) 2012-03-28 2013-03-14 Extracto crudo de un híbrido de sechium edule, método para su extracción y su uso para formulaciones con efecto antineoplásico
EP13769895.7A EP2886124A4 (en) 2012-03-28 2013-03-14 A ROHEXTRACT FROM A CHAYOTE HYBRID, METHOD FOR THE EXTRACTION THEREOF AND USE THEREOF FOR FORMULATIONS WITH ANTINEOPLASTIC EFFECT
US14/388,405 US20150064289A1 (en) 2012-03-28 2013-03-14 Raw Extract of a Sechium Edule Hybrid, Method for Extracting Same and Use Thereof for Formulations Having an Antineoplastic Effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012003818A MX357329B (es) 2012-03-28 2012-03-28 Extracto crudo de un hibrido de sechium edule, metodo para su extraccion y su uso para formulaciones con efecto antineoplasico.

Publications (2)

Publication Number Publication Date
MX2012003818A MX2012003818A (es) 2013-09-30
MX357329B true MX357329B (es) 2018-07-05

Family

ID=49260735

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012003818A MX357329B (es) 2012-03-28 2012-03-28 Extracto crudo de un hibrido de sechium edule, metodo para su extraccion y su uso para formulaciones con efecto antineoplasico.

Country Status (4)

Country Link
US (1) US20150064289A1 (es)
EP (1) EP2886124A4 (es)
MX (1) MX357329B (es)
WO (1) WO2013147578A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100429224C (zh) 2003-09-29 2008-10-29 中国科学院福建物质结构研究所 南瓜蛋白的抗肿瘤活性及其应用

Also Published As

Publication number Publication date
WO2013147578A9 (es) 2015-03-12
EP2886124A4 (en) 2016-06-08
US20150064289A1 (en) 2015-03-05
EP2886124A1 (en) 2015-06-24
MX2012003818A (es) 2013-09-30
WO2013147578A1 (es) 2013-10-03

Similar Documents

Publication Publication Date Title
WO2016004068A8 (en) Hydrogel compositions comprising encapsulated cells and methods of use thereof
WO2013170068A3 (en) Nuclear transport modulators and uses thereof
EP3904502A3 (en) Compositions and methods
MX2013004061A (es) Analogos de ciclosporina.
SG11201406141UA (en) Immortalized stem cells and medicinal composition and medicinal preparation comprising product thereof as active ingredient
WO2013188847A8 (en) Compositions and methods for transmucosal absorption
NZ708016A (en) Lyophilized preparations of melphalan flufenamide
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
WO2015033302A3 (en) Fulvestrant compositions
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2013114394A3 (en) A polyherbal composition for skin care
WO2012130820A3 (de) Isopentylester zur verwendung in kosmetischen, dermatologischen oder pharmazeutischen kompositionen
MX2013004062A (es) Analogos de ciclosporina.
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
WO2015023649A3 (en) Peptides for enhancing transdermal delivery
EA036036B1 (ru) Композиции, содержащие циклоспорин
IN2014MN02269A (es)
PH12015501377A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MX357704B (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
MX2015005111A (es) Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.
HK1208345A1 (en) Extract of cotton fibres and costmetic composition and use thereof for protecting, nourishing and hydrating the skin
MX2016005976A (es) Formulaciones de tripeptido liofilizado estables en almacenamiento.
MX355719B (es) Composicion farmaceutica en forma de una suspension oral que comprende una fraccion flavonoica y goma de xantano.
EP2886112A4 (en) COMPOSITION CONTAINING AS ACTIVE INGREDIENT OF S-ALLYL-L-CYSTEINE FOR PREVENTING OR TREATING OCULAR DISEASES, AND PHARMACEUTICAL FORMULATION COMPRISING THE SAME
EP2875823A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHIES CONTAINING HENOSIS STAPF EXTRACT FROM VAR. MUNRO OF PHYLLOSTACHYS NIGRA AS ACTIVE INGREDIENT

Legal Events

Date Code Title Description
FG Grant or registration